COPD in France: Deadly Lung Disease Affecting Millions

Chronic obstructive pulmonary disease remains largely unfamiliar to the general public, yet it poses a significant health threat in France, where it claims lives and impacts the daily existence of three million individuals nationwide.

A Silent Epidemic: The Challenge of COPD in France

Despite quietly ranking among the leading causes of death in France, chronic obstructive pulmonary disease (COPD)—known locally as BPCO—remains largely off the public radar. Roughly 3 to 3.5 million people in the country are affected, yet the level of public awareness lags far behind other major health issues. According to a recent survey by Sanofi and BVA Xsight, nearly three-quarters of French citizens feel poorly informed about respiratory diseases, with an astonishing 63% admitting they have never even heard of BPCO.

Common Symptoms, Widespread Misunderstanding

The early warning signs—persistent cough, shortness of breath, chronic fatigue—are all too often dismissed as mere consequences of aging or long-term smoking. This widespread misinterpretation leads many to ignore their symptoms, especially as the very term “BPCO” seems abstract and technical. As Professor Maëva Zysman, a pulmonologist at Bordeaux University Hospital, explains, the acronym itself can be alienating, masking the gravity of the condition. Many hesitate to speak up about their health for fear it will force a difficult conversation about quitting smoking. Consequently, diagnoses usually come late, when damage is already significant. The situation is aggravated by the fact that most general practitioners lack essential tools such as spirometers, making early detection even more elusive.

Breaking the Inactivity Cycle

Once diagnosed, patients frequently find themselves trapped in a downward spiral: inactivity leads to greater breathlessness and fatigue, discouraging further movement. Only about 27% of those affected manage to engage in at least half an hour of tailored exercise each day—a figure that underscores just how difficult it is to escape this vicious cycle. Several factors explain this persistent problem:

• Lack of accessible rehabilitation programs in local communities.
• Insufficient promotion of exercise as an integral part of treatment.
• Pervasive stigma and misunderstandings around respiratory illnesses.

To address these gaps, organizations such as Santé respiratoire France have launched platforms like Respiragora (with directories and specialist resources), while YouTube’s Respi’Mouv series makes practical exercises widely available.

Toward Better Prevention and Support

A coordinated response involving general practitioners, pharmacists, physiotherapists—and above all, increased public education—is now viewed as essential for tackling this stealthy disease head-on. Without stronger collective engagement on early intervention and information-sharing about COPD, millions remain at risk of suffering its effects unnoticed and untreated. For many experts in France’s respiratory care community, a renewed effort in awareness and prevention could make all the difference for those most vulnerable.